Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 13/20 | 0.40 |
| ▸ | CNR1 | P21554 | 6/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8028164 | 0.93 | F2 (0.45) | F2HCRTR2CNR2CNR1POLB | |
| SCHEMBL8026373 | 0.92 | CNR2 (0.46) | F2HCRTR2CNR2CNR1BCHE | |
| SCHEMBL8016208 | 0.92 | CNR2 (0.47) | F2HCRTR2CNR2CNR1POLB | |
| SCHEMBL8030583 | 0.92 | CNR2 (0.45) | F2CNR2CNR1BCHE | |
| SCHEMBL8030064 | 0.91 | HCRTR2 (0.43) | F2HCRTR2CNR2CNR1POLB | |
| SCHEMBL8028097 | 0.90 | CNR2 (0.48) | F2HCRTR2CNR2CNR1POLB | |
| SCHEMBL8032466 | 0.90 | F2 (0.52) | F2HCRTR2POLBUSP2MAPK1 | |
| SCHEMBL8031603 | 0.89 | CNR2 (0.47) | F2CNR2CNR1BCHE | |
| SCHEMBL8029957 | 0.88 | F2 (0.40) | F2HCRTR2CNR2CNR1POLB | |
| SCHEMBL8127249 | 0.88 | CNR2 (0.44) | F2CNR2CNR1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1060166-A1 | FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS | Boehringer Ingelheim Pharma KG (DE) | 2000-12-20 | — | — | EP | disclosed |
| US-6114532-A | ANTICOAGULANT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-05 | — | — | US | disclosed |
| WO-1999040072-A1 | FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-08-12 | — | — | WO | disclosed |